医学
缓和医疗
临床试验
重症监护医学
生活质量(医疗保健)
随机对照试验
急诊医学
心情
相(物质)
临床研究阶段
梅德林
初级保健
物理疗法
作者
Heidrun Golla,Charlotte Nettekoven,Martin Hellmich,Iris Appelmann,Claudia Bausewein,Gerhild Becker,Christopher S. Boehlke,Tzvetina Brumbarova,Daniele Civello,Hans Clusmann,Birgit Haberland,Dieter Henrik Heiland,Ulrich Herrlinger,Birgit Jaspers,Melanie Joshi,Dirk Mülller,Wiebke Müller,Chuh-Hyoun Na,Martin Neukirchen,Lukas Radbruch
出处
期刊:Neuro-oncology
[Oxford University Press]
日期:2025-10-10
卷期号:28 (1): 226-240
被引量:22
标识
DOI:10.1093/neuonc/noaf230
摘要
BACKGROUND: Positive effects of early integration of palliative care (EIPC) have been shown for systemic solid malignant tumors. We tested the hypothesis that EIPC improves quality of life (QoL), palliative care (PC) problems and mood in glioblastoma patients and reduces caregiver burden. METHODS: This randomized, rater-blinded, controlled trial conducted in six German university medical centers included glioblastoma patients within four weeks after diagnosis (first/recurrent) and their caregivers. Patients received standard care (control) or standard care and EIPC (intervention) for 12 months. Primary outcome was change in QoL after six months measured by the trial outcome index of the FACT-Br. Data were assessed 3-monthly for up to 24 months. RESULTS: Between 05/2019 and 04/2021 patients were enrolled and randomized to the intervention (n = 109) or control group (n = 108). QoL at month six was in favor of the intervention, however not statistically significant (mean difference 4.1 with 95% CI, -4.4 to 12.6, P = .34; intervention: n = 98 (m = 54/f = 44); control: n = 89 (m = 50/f = 39)). In an analysis adjusted for time of death, performed because of a significant survival difference (control superior to intervention, P = .018), QoL was better in the intervention group (P = .041). Secondary outcomes showed that patients significantly benefited from EIPC regarding PC problems and mood especially after intervention ended, while caregivers did not seem to benefit. CONCLUSIONS: Provided that the survival difference is included in the analysis, EIPC improves QoL in glioblastoma patients. This, in addition to improved mood and PC problems, demonstrates that EIPC sustainably improves 'how to live' but not 'length of life'.
科研通智能强力驱动
Strongly Powered by AbleSci AI